ReviewClinical and translational science2025

Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials.

Nicki M Kyriacou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.